MS Trial Alert: Investigators Studying E
MS Trial Alert: Investigators Studying ELND002, Subcutaneous Drug in 125 People with Relapsing MS http://ow.ly/2SgPl
Recent Posts
Archives
- November 2018
- September 2018
- July 2018
- June 2018
- February 2018
- November 2017
- October 2017
- August 2017
- June 2017
- May 2017
- April 2017
- March 2017
- February 2017
- January 2017
- November 2016
- October 2016
- September 2016
- August 2016
- July 2016
- June 2016
- May 2016
- April 2016
- March 2016
- February 2016
- January 2016
- December 2015
- November 2015
- October 2015
- September 2015
- August 2015
- July 2015
- June 2015
- May 2015
- April 2015
- March 2015
- February 2015
- January 2015
- December 2014
- November 2014
- October 2014
- September 2014
- August 2014
- July 2014
- June 2014
- May 2014
- March 2014
- February 2014
- January 2014
- December 2013
- November 2013
- October 2013
- September 2013
- August 2013
- July 2013
- June 2013
- May 2013
- April 2013
- March 2013
- February 2013
- January 2013
- December 2012
- November 2012
- August 2012
- July 2012
- June 2012
- May 2012
- April 2012
- March 2012
- January 2012
- December 2011
- November 2011
- October 2011
- November 2010
- October 2010
- September 2010
Categories
- ADHD
- AIM sponsorships
- Brain MRI
- Canada
- Cancer Research
- Dental MRI
- Diffusion MRI
- Dr. Attariwala
- Early Cancer Detection
- Health and Canada
- Home
- Knee MRI
- Medical Imaging
- MRI
- MRI arthritis
- MRI Arthrogram
- MRI Canada
- MRI Research
- MRI Vancouver
- MyCare Insurance
- Prenuvo
- Radiologist
- Radiology
- Social Media and Health
- Sport MRI
- Uncategorised
- Video
- Whole Body MRI